Oriola’s Privacy notice has been updated

4.6.2018

At Oriola, the preparations for the EU General Data Protection Regulation (GDPR) started in the beginning of 2017. According to Oriola’s Legal Councel Petter Sandström, external professionals as well as all business areas at Oriola Sweden and Finland were engaged in the extensive project, and the project was successfully completed by May 25, 2018.

More news

29.11.2023 | News

Welcome to Oriola’s Pharmacovigilance Breakfast event in Stockholm on January 18th 2024

Oriola’s Pharmacovigilance (PV) team is delighted to invite you to a breakfast event in Stockholm on January 18th, 2024. The PV Breakfast serves as a platform for participants to engage in discussions, share insights and stay updated on the current state of affairs in pharmacovigilance and drug safety. The theme of our first PV Breakfast event is “Pharmacovigilance in the Digital Era”.

14.11.2023 | News

First time in the Finnish pharmaceutical market? Join our webinar!

Successfully introducing a new medicinal product to the Finnish market requires expertise. Whether you are planning to enter the Finnish market or have already launched but feel that you still lack country-specific knowledge, this training is designed for you.

04.11.2023 | News

Medicine’s product information texts – what happens after regulatory approval?

A medicine’s product information (summary of product characteristics, package leaflet and labelling) contains essential information that healthcare professionals and patients using the medicine need to know about its use. Our experts have compiled a list of things that you may need to remember after the approval of a variation requiring changes to the product information.